Amphastar Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Amphastar Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29% to $644,395,000. The net income raised on $137,545,000 and profit margin reached 21%. Total operating expenses were $154,134,000.
Profit Margin
| 2014 | 210.46M | -10.69M | -5.08% |
|---|---|---|---|
| 2015 | 251.51M | -2.78M | -1.11% |
| 2016 | 255.16M | 10.53M | 4.13% |
| 2017 | 240.17M | 4.50M | 1.88% |
| 2018 | 294.66M | -5.73M | -1.95% |
| 2019 | 322.35M | 48.93M | 15.18% |
| 2020 | 349.84M | 1.09M | 0.31% |
| 2021 | 437.76M | 62.11M | 14.19% |
| 2022 | 498.98M | 91.38M | 18.31% |
| 2023 | 644.39M | 137.54M | 21.34% |
AMPH Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 644.39M | 498.98M | 437.76M | 349.84M | 322.35M | 294.66M | 240.17M | 255.16M | 251.51M | 210.46M |
Cost of revenue | 293.27M | 250.12M | 238.02M | 206.50M | 190.43M | 187.68M | 149.38M | 150.97M | 174.17M | 159.20M |
Gross profit | 351.12M | 248.86M | 199.73M | 143.34M | 131.92M | 106.98M | 90.79M | 104.18M | 77.34M | 51.25M |
Operating exp. | ||||||||||
Research and development | 73.74M | 74.77M | 60.93M | 67.22M | 68.85M | 57.56M | 43.41M | 41.19M | 37.06M | 28.42M |
Selling and marketing | 28.85M | 21.53M | 17.48M | 14.78M | 12.83M | 8.15M | 6.46M | 5.46M | 5.47M | 5.56M |
Total operating expenses | 154.13M | 141.36M | 129.85M | 132.38M | 131.96M | 115.60M | 94.33M | 88.49M | 84.03M | 68.8M |
Operating income | 196.98M | 78.75M | 43.13M | -14.22M | -39K | -8.62M | -895K | 15.69M | -6.89M | -17.98M |
Other income (expenses), net | -25.62M | 37.28M | 41.00M | -6.31M | 60.26M | -1.30M | 2.51M | -746K | -3.46M | -165K |
Income before tax | 171.35M | 116.04M | 84.13M | 4.63M | 60.22M | -9.92M | 1.62M | 14.94M | -10.36M | -18.14M |
Income tax expense | 31.83M | 23.47M | 20.63M | 3.54M | 13.72M | -3.26M | -2.88M | 4.41M | -7.57M | -7.44M |
Net income | 137.54M | 91.38M | 62.11M | 1.09M | 48.93M | -5.73M | 4.50M | 10.53M | -2.78M | -10.69M |
Earnings per share | ||||||||||
Basic EPS | 2.85 | 1.88 | 1.3 | 0.02 | 1.04 | -0.12 | 0.1 | 0.23 | -0.06 | -0.25 |
Diluted EPS | 2.6 | 1.74 | 1.25 | 0.02 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |